Clinical Trials Directory

Trials / Completed

CompletedNCT02302690

Immunity Against AAV in Crigler Najjar Patient

Study of the Prevalence of Pre-existing Immunity Against the Adeno-associated Virus (AAV) in Patients With Crigler-Najjar Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
49 (actual)
Sponsor
Genethon · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The proposed research protocol aims at addressing these points by pre-screening CN patients for their AAV serology in link with their medical history and current medical status. A first objective is to assess the presence of neutralizing AAV antibodies in the serum of CN patients.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood sample for immunology

Timeline

Start date
2014-11-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2014-11-27
Last updated
2017-12-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02302690. Inclusion in this directory is not an endorsement.

Immunity Against AAV in Crigler Najjar Patient (NCT02302690) · Clinical Trials Directory